8-67422581-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_020361.5(CPA6):c.1237C>T(p.Leu413Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000589 in 1,614,032 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020361.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA6 | NM_020361.5 | c.1237C>T | p.Leu413Phe | missense_variant | Exon 11 of 11 | ENST00000297770.10 | NP_065094.3 | |
CPA6 | XM_017013646.2 | c.793C>T | p.Leu265Phe | missense_variant | Exon 11 of 11 | XP_016869135.1 | ||
ARFGEF1-DT | NR_136224.1 | n.470-19629G>A | intron_variant | Intron 1 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00250 AC: 381AN: 152118Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.000664 AC: 167AN: 251412Hom.: 0 AF XY: 0.000427 AC XY: 58AN XY: 135864
GnomAD4 exome AF: 0.000389 AC: 569AN: 1461796Hom.: 4 Cov.: 31 AF XY: 0.000353 AC XY: 257AN XY: 727212
GnomAD4 genome AF: 0.00250 AC: 381AN: 152236Hom.: 5 Cov.: 32 AF XY: 0.00215 AC XY: 160AN XY: 74424
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
The CPA6 p.Leu413Phe variant was not identified in the literature but was identified in dbSNP (ID: rs142597675), ClinVar (classified as likely benign by Center for Pediatric Genomic Medicine, Children's Mercy Hospital and EGL Genetics) and LOVD 3.0 (classified as likely benign). The variant was identified in control databases in 240 of 282796 chromosomes (1 homozygous) at a frequency of 0.000849 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 213 of 24962 chromosomes (freq: 0.008533), Other in 3 of 7224 chromosomes (freq: 0.000415), Latino in 13 of 35436 chromosomes (freq: 0.000367), European (non-Finnish) in 9 of 129114 chromosomes (freq: 0.00007) and South Asian in 2 of 30616 chromosomes (freq: 0.000065), but was not observed in the Ashkenazi Jewish, East Asian and European (Finnish) populations. The p.Leu413 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. However a study of CPA6 variants reported in the general population suggests that although leucine and phenylalanine are similar in size, phenylalanine is a little larger and this may displace the hydrodynamic balance of surrounding residues (Sapio_2012_PMID: 23105115). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
not specified Benign:1
- -
Febrile seizures, familial, 11 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at